Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-11,065
Closed -$535K 1030
2016
Q1
$535K Sell
11,065
-3,975
-26% -$153K 0.03% 552
2015
Q4
$591K Hold
15,040
0.03% 465
2015
Q3
$571K Hold
15,040
0.04% 479
2015
Q2
$598K Buy
+15,040
New +$469K 0.03% 564
2014
Q3
Sell
-11,637
Closed -$195K 964
2014
Q2
$195K Buy
+11,637
New +$165K 0.01% 897
2014
Q1
Sell
-11,256
Closed -$165K 918
2013
Q4
$165K Hold
11,256
0.01% 953
2013
Q3
$194K Buy
+11,256
New +$167K 0.01% 920

Other funds holding AMED

Deere & Company's AMED Position: Q2 2016 in Review

Deere & Company sold out of Amedisys (AMED) in Q2 2016, closing a stake of 11,065 shares — an estimated $535K sold.

Deere & Company first reported a position in AMED in Q3 2013 and held it in 7 quarters. The position peaked at $598K in Q2 2015. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

  • Deere & Company reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
  • Deere & Company sold 11,065 Amedisys shares in Q2 2016, an estimated $535K.
  • Deere & Company first reported a position in Amedisys in Q3 2013 and held it in 7 quarters.
  • Deere & Company's Amedisys position peaked at $598K in Q2 2015.
  • 168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on Deere & Company's 13F filing for Q2 2016, filed 11 Aug 2016.